Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA)

Q: What does CUSIP G9TY5A101 represent in this 13F holders report?

CUSIP G9TY5A101 is the security identifier for ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share in Q2 2025?

62 institutional investors reported ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: G9TY5A101

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Class A Ordinary Shares, par value $0.0001 per share
Shares outstanding: 99,155,394
Total 13F shares: 35,347,572
Share change: -10,384,413
Total reported value: $37,112,793
Price per share: $1.05
Number of holders: 62
Value change: -$12,588,212
Number of buys: 34
Number of sells: 49

Quarterly Holders Quick Answers

What is CUSIP G9TY5A101?
CUSIP G9TY5A101 identifies ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP G9TY5A101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BARCLAYS PLC	3/4/5 13F	10%+ Owner · Company	0.06% from 13F	2,340,240	$24,349,729	—	09 Jan 2023	3/4/5 13F
VR Adviser, LLC	13F	Company	5.1%	5,023,166	$6,479,884	—	31 Mar 2025	13F
SUVRETTA CAPITAL MANAGEMENT, LLC	13F	Company	4.9%	4,860,939	$6,270,611	—	31 Mar 2025	13F
RA CAPITAL MANAGEMENT, L.P.	13D/G 13F	Company	4.9%	3,217,503	$4,633,204	$0	31 Dec 2024	13D/G 13F
Someit Sidhu	3/4/5	Director	— mixed-class rows	1,479,956 mixed-class rows	$4,338,550	—	21 May 2025	3/4/5
PFIZER INC	13D/G 3/4/5 13F	Pfizer Inc. 13-5315170 · 10%+ Owner · Company	4.6%	2,970,022	$4,276,832	$0	31 Dec 2024	13D/G 3/4/5 13F
Deep Track Capital, LP	13F	Company	3.3%	3,283,783	$4,236,080	—	31 Mar 2025	13F
GREAT POINT PARTNERS LLC	13F	Company	3.2%	3,170,194	$4,089,550	—	31 Mar 2025	13F
ADAR1 Capital Management, LLC	13F 13D/G	Company	3.2% from 13D/G	2,801,184	$3,613,527	—	31 Mar 2025	13F 13D/G
BlackRock, Inc.	13F	Company	2.7%	2,721,752	$3,511,060	—	31 Mar 2025	13F
JPMORGAN CHASE & CO	13F	Company	2.6%	2,607,219	$3,363,312	—	31 Mar 2025	13F
BRAIDWELL LP	13F	Company	2.5%	2,472,806	$3,189,920	—	31 Mar 2025	13F
Point72 Asset Management, L.P.	13F	Company	2.4%	2,350,000	$3,031,500	—	31 Mar 2025	13F
Allostery Investments LP	13F	Company	2.3%	2,329,384	$3,004,905	—	31 Mar 2025	13F
Amit Munshi	3/4/5	Director	— mixed-class rows	828,384 mixed-class rows	$2,433,212	—	21 May 2025	3/4/5
ARMISTICE CAPITAL, LLC	13F	Company	1.5%	1,536,000	$1,981,440	—	31 Mar 2025	13F
Verender S. Badial	3/4/5	Chief Financial Officer	— mixed-class rows	820,619 mixed-class rows	$1,412,827	—	08 May 2025	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1%	993,016	$1,281,214	—	31 Mar 2025	13F
VANGUARD GROUP INC	13F	Company	0.85%	842,158	$1,086,384	—	31 Mar 2025	13F
Michael Howell	3/4/5	Chief Scientific Officer and Head of Translational Science	— mixed-class rows	529,904 mixed-class rows	$1,063,813	—	18 Jun 2024	3/4/5
STATE STREET CORP	13F	Company	0.53%	522,292	$673,757	—	31 Mar 2025	13F
Woodline Partners LP	13F	Company	0.52%	520,276	$671,156	—	31 Mar 2025	13F
Christopher Cabell	3/4/5	CMO & Head of R&D	— class O/S missing	162,060	$648,240	—	18 May 2023	3/4/5
Arnout Ploos van Amstel	3/4/5	Director	— mixed-class rows	151,000 mixed-class rows	$620,000	—	21 May 2025	3/4/5
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.43%	422,223	$544,668	—	31 Mar 2025	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.42%	421,229	$543,385	—	31 Mar 2025	13F
NORTHERN TRUST CORP	13F	Company	0.37%	369,358	$476,472	—	31 Mar 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.31%	303,573	$391,609	—	31 Mar 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.29%	288,601	$372,295	—	31 Mar 2025	13F
Affinity Asset Advisors, LLC	13F	Company	0.23%	223,335	$288,102	—	31 Mar 2025	13F
RAYMOND JAMES FINANCIAL INC	13F	Company	0.15%	144,685	$186,643	—	31 Mar 2025	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.12%	122,976	$158,639	—	31 Mar 2025	13F
Forefront Analytics, LLC	13F	Company	0.11%	108,308	$139,801	—	31 Mar 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.09%	94,055	$121,331	—	31 Mar 2025	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.09%	86,900	$112,101	—	31 Mar 2025	13F
Bank of New York Mellon Corp	13F	Company	0.09%	85,917	$110,833	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	0.08%	83,909	$108,243	—	31 Mar 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	65,042	$83,904	—	31 Mar 2025	13F
Nuveen, LLC	13F	Company	0.06%	58,961	$76,060	—	31 Mar 2025	13F
UBS Group AG	13F	Company	0.06%	58,853	$75,920	—	31 Mar 2025	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.06%	55,702	$71,855	—	31 Mar 2025	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	36,577	$47,178	—	31 Mar 2025	13F
CITIGROUP INC	13F	Company	0.04%	35,968	$46,398	—	31 Mar 2025	13F
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	13F	Company	0.03%	30,820	$39,758	—	31 Mar 2025	13F
INTECH INVESTMENT MANAGEMENT LLC	13F	Company	0.03%	29,545	$38,113	—	31 Mar 2025	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	28,840	$37,204	—	31 Mar 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	28,794	$37,144	—	31 Mar 2025	13F
Corebridge Financial, Inc.	13F	Company	0.02%	24,728	$31,899	—	31 Mar 2025	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.02%	24,117	$31,111	—	31 Mar 2025	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.02%	22,702	$29,000	—	31 Mar 2025	13F

Institutional Holders of Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA) as of Q2 2025

As of 30 Jun 2025, Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,347,572 shares. The largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, VR ADVISER, LLC, GREAT POINT PARTNERS LLC, Pfizer Inc, BRAIDWELL LP, Point72 Asset Management, L.P., Deep Track Capital, LP, ARMISTICE CAPITAL, LLC, and ADAR1 Capital Management, LLC. This page lists 62 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

-12

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.